Biologics to 2015 - Freedonia Market Research

Biologics to 2015

Biologics to 2015 - Freedonia Market Research
Biologics to 2015
Published Sep 01, 2011
376 pages — Published Sep 01, 2011
Price US$ 4,900.00  |  Buy this Report Now

This report is also available for purchase on a per-page basis.

About This Report

  
Abstract:

US demand for biologics is expected to grow 6.5 percent annually through 2015, driven by dramatic shifts in production technology and more targeted diseases such as cancer, diabetes and other serious medical conditions. Monoclonal antibodies will remain the largest category and be one of the fastest growing segments, outpaced only by hormones.This study analyzes the $74.3 billion US biologics industry. It presents historical demand data for the years 2000, 2005 and 2010, and forecasts for 2015 and 2020 by product (e.g., monoclonal antibodies, vaccines and toxoids, hormones, growth factors, immunomodulators, blood and blood products, enzymes, coagulation factors) and application (e.g., human health care, animal health, research).The study also considers market environment factors, details industry structure, evaluates company market share and profiles 44 industry competitors, including Roche, Amgen and Sanofi-Aventis.

  
Source:
Document ID
2792
Country
Industry
Industry
Industry
Industry
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
EXECUTIVE SUMMARY63
MARKET ENVIRONMENT947
  General102
  Demographic Patterns124
  Macroeconomic Outlook164
  Healthcare Trends202
    National Health Expenditures224
    Pharmaceutical Supply &Demand261
    Pharmaceutical Shipments by Therapeutic Class273
  Patient Activity303
  Medical Conditions332
    Acute Conditions351
    Chronic Conditions362
  Animal Health Industry Outlook383
  Technological Overview of Biologics412
    Recombinant DNA Biologics431
    Biosimilars444
  Regulation481
    Regulation of Human Biologic Therapies493
    Regulation of Biosimilar Products522
    Regulation of Biologics Research &Testing Products541
    Regulation of Animal Biologics551
PRODUCTS5687
  General572
  Demand by Type596
  Monoclonal Antibodies653
    Cancer Treatment681
    Rheumatoid Arthritis691
    Macular Degeneration701
    Psoriasis711
    Infectious Disease721
    Other Applications731
  Vaccines &Toxoids742
    Vaccines for Human Health764
    Animal Vaccines801
  Hormones812
    Insulin832
    Human Growth Hormone852
    Teriparatide871
    Follicle-Stimulating Hormone881
    Estrogen891
    Calcitonin901
    Thyrotropin911
    Corticotropin921
    Other Hormones931
  Growth Factors942
    Erythropoietins962
    Colony-Stimulating Factors982
    Bone Morphogenetic Proteins1002
    Other Growth Factors1021
  Immunomodulators1032
    Immunosuppressing Agents1052
    Interferons1072
    Other Immunomodulators1092
  Blood &Blood Products1113
    Plasma &Plasma Fractions1142
    Whole Blood1161
    Cellular Components1174
  Enzymes1212
    Enzyme Replacement Therapies1233
    Neuromodulators1262
    Digestive Enzymes1282
    Thrombolytics1302
    Diagnostics1322
    Other Enzymes1341
  Coagulation Factors1352
    Antihemophilics1372
    Other Coagulation Factors1391
  Other Biologics1403
APPLICATIONS14334
  General1442
  Human Healthcare1469
    Cancer1555
    Autoimmune Diseases1603
    Infectious Diseases1633
    Blood Disorders1663
    Diabetes1692
    Other Conditions1713
  Biologics for Other Uses1741
    Animal Health1751
    Research &All Other Applications1761
INDUSTRY STRUCTURE17747
  General1783
  Market Share18114
  Competitive Strategies1952
  Mergers &Acquisitions1975
  Licensing &Related Agreements20216
  Research &Development2182
  Manufacturing2202
  Marketing &Distribution2222
Company Profiles224153
  Abbott Laboratories2254
  Alere Incorporated2292
  Alexion Pharmaceuticals Incorporated2312
  Allergan Incorporated2332
  American Red Cross2352
  Amgen Incorporated2376
  Aptalis Pharma Incorporated2432
  AstraZeneca plc2453
  Baxter International Incorporated2482
  Bayer AG2502
  Biogen Idec Incorporated2522
  BioMarin Pharmaceutical Incorporated2542
  Blood Systems Incorporated2562
  Bristol-Myers Squibb Company2583
  CSL Limited2614
  EKR Therapeutics Incorporated2651
  Eli Lilly &Company2664
  Emergent BioSolutions Incorporated2705
  GlaxoSmithKline plc2756
  Halozyme Therapeutics Incorporated2814
  Intercell AG2854
  Ipsen2892
  Johnson &Johnson2917
  Lonza Group Limited2985
  Lundbeck (H.) A/S3032
  Massachusetts Biologic Laboratories3052
  Medtronic Incorporated3072
  Merck &Company Incorporated3097
  Merck KGaA3162
  New York Blood Center3182
  Novartis AG3207
  Novo Nordisk A/S3272
  Pfizer Incorporated3297
  Questcor Pharmaceuticals Incorporated3361
  Roche Holding Limited3378
  Sanofi-Aventis34510
  Shire plc3553
  sigma-tau Group3582
  Solvay SA3601
  Stryker Corporation3611
  Teva Pharmaceutical Industries Limited3623
  US WorldMeds LLC3651
  ViaCyte Incorporated3662
  WiCell Research Institute3681
  Other Companies Mentioned in Study3698

Table Of Contents

Freedonia Market Research—Reports provide industry insights targeting market size, product and market segmentation, product and market forecasts, industry composition, market leaders and business trends.

About the Author


Cite this Report

  
MLA:
Freedonia Market Research. "Biologics to 2015" Sep 01, 2011. Alacra Store. Dec 06, 2016. <http://www.alacrastore.com/storecontent/Freedonia-Market-Research/Biologics-to-2015-2039-463>
  
APA:
Freedonia Market Research. (2011). Biologics to 2015 Sep 01, 2011. New York, NY: Alacra Store. Retrieved Dec 06, 2016 from <http://www.alacrastore.com/storecontent/Freedonia-Market-Research/Biologics-to-2015-2039-463>
  
US$ 4,900.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Market Research from one place.